Here: an overview of atezolizumab, the first new drug in two decades for bladder cancer and now approved for NSCLC.
Gregory D. Greenier
Advertisement
2017 PharmD Candidate at University of Connecticut School of Pharmacy, Storrs, Conn.
Articles by Gregory D. Greenier
Advertisement
Latest Updated Articles
- Atezolizumab for Urothelial Carcinoma and Non-Small Cell Lung Cancer
February 8th 2017
Advertisement
Advertisement
Trending on Drug Topics
1
The Drug Price Paradox: PBMs, Pharmacies, and the Path to Affordability
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
Ixekizumab, Tirzepatide Maintains Efficacy in Psoriatic Disease
4
How mRNA and Protein-Based COVID-19 Vaccines Work
5